Ligand-functionalized substrates with enhanced binding capacity

US10352835B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10352835-B2
Application numberUS-201815936767-A
CountryUS
Kind codeB2
Filing dateMar 27, 2018
Priority dateOct 3, 2013
Publication dateJul 16, 2019
Grant dateJul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An article that can be used for biomaterial capture comprises (a) a porous substrate; and (b) borne on the porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to the monovalent groups so as to link at least one ethylenically unsaturated group and at least one ligand functional group by a chain of at least six catenated atoms.

First claim

Opening claim text (preview).

We claim: 1. An article for biomaterial capture comprising (a) a porous substrate; and (b) grafted on said porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof, and (3) a multivalent spacer group that is directly bonded to said monovalent groups so as to link at least one said ethylenically unsaturated group and at least one said ligand functional group by a chain of at least six catenated atoms (c) wherein said monomer is of the formula: CH 2 ═CR 1 —C(═O)—X—R 2 —[Z—R 2 ] n -L wherein R 1 is selected from hydrogen, alkyl, cycloalkyl, aryl, and combinations thereof; each R 2 is independently selected from hydrocarbylene, heterohydrocarbylene, and combinations thereof; X is —O— or —NR 3 —, where R 3 is selected from hydrogen, hydrocarbyl, heterohydrocarbyl, and combinations thereof; Z is heterohydrocarbylene comprising at least one hydrogen bond donor, at least one hydrogen bond acceptor, or a combination thereof; n is 1; and L is a heteroatom-containing group comprising at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof. 2. The article of claim 1 , wherein said porous substrate is a porous membrane; and/or wherein said porous substrate is polymeric. 3. The article of claim 1 wherein said monovalent ethylenically unsaturated group is selected from ethenyl, 1-alkylethenyl, and combinations thereof. 4. The article of claim 1 or any other of the preceding claims, wherein said monovalent ligand functional group is selected from carboxy, phosphono, phosphato, sulfono, sulfato, boronato, tertiary amino, quaternary amino, and combinations thereof. 5. The article of claim 1 or any other of the preceding claims, wherein said multivalent spacer group is a catenated heteroatom-containing hydrocarbon group. 6. The article of claim 5 , wherein said hydrogen bonding moiety is selected from carbonylimino, thiocarbonylimino, iminocarbonylimino, iminothiocarbonylimino, oxycarbonylimino, oxythiocarbonylimino, and combinations thereof. 7. The article of claim 1 wherein said chain has at least seven catenated atoms. 8. The article of claim 1 wherein said chain has no more than 50 catenated atoms. 9. The article of claim 1 wherein said chain has from 8 to 16 catenated atoms. 10. The article of claim 1 wherein said polymer is grafted to said porous substrate. 11. A process for preparing an article for biomaterial capture comprising (a) providing a porous substrate; and (b) grafting said porous substrate with a polymer comprising interpolymerized units of at least one monomer of the formula: CH 2 ═CR 1 —C(═O)—X—R 2 —[Z—R 2 ] n -L wherein R 1 is selected from hydrogen, alkyl, cycloalkyl, aryl, and combinations thereof; each R 2 is independently selected from hydrocarbylene, heterohydrocarbylene, and combinations thereof; X is —O— or —NR 3 —, where R 3 is selected from hydrogen, hydrocarbyl, heterohydrocarbyl, and combinations thereof; Z is heterohydrocarbylene comprising at least one hydrogen bond donor, at least one hydrogen bond acceptor, or a combination thereof; n is 1; and L is a heteroatom-containing group comprising at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, and salts thereof.

Assignees

Inventors

Classifications

  • Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group · CPC title

  • Polyamides, e.g. polyester-amides · CPC title

  • Membrane materials having positively charged functional groups · CPC title

  • Graft polymerization · CPC title

  • using wave energy or particle radiation · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10352835B2 cover?
An article that can be used for biomaterial capture comprises (a) a porous substrate; and (b) borne on the porous substrate, a polymer comprising interpolymerized units of at least one monomer consisting of (1) at least one monovalent ethylenically unsaturated group, (2) at least one monovalent ligand functional group selected from acidic groups, basic groups other than guanidino, an…
Who is the assignee on this patent?
3M Innovative Properties Co
What technology area does this patent fall under?
Primary CPC classification G01N1/405. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).